Auauniversity

AUA2022 Presidential Address Speaker: Raju Thomas, MD, FACS, FRCS, MHA Urology Chair, Tulane University Medical Center and AUA President Tulane University

PARP Inhibitors in Advanced Prostate Cancer Care Podcast CME Available: https://auau.auanet.org/node/37321 Host: Jay D. Raman, MD, FACS Guests: Maha Hussain, MD and Ganesh Raj, MD, PhD LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Identify approved PARP Inhibitors for prostate cancer and patients who may benefit from PARP Inhibitor‐based therapy. 2. Evaluate available clinical safety and efficacy data for PARP Inhibitors. 3. Describe indications and contraindications for PARP Inhibitors in patients with advanced prostate cancer. 4. Identify how to manage adverse events that patients may experience while taking a PARP Inhibitors. ACKNOWLEDGEMENTS: This series is supported by independent educational grants from: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc. Sanofi Genzyme

Advancing Women in Urology: Sponsorship and It’s Role in Career Advancement in Medicine Host: Jay D. Raman, MD, FACS Guest: Peggy Pearle, MD and Simone Thavaseelan, MD Outline: Segment #1 Defining Sponsorship Segment #2 Role in Career Advancement/Importance Segment #3 Identifying the Issue Segment #4 Key Characteristics of healthy/effective Sponsorship Segment #5 Opportunities for Action ACKNOWLEDGEMENT This educational series was made possible by support from Urovant Resources: Jain, S. Why Sponsorship in Medicine Matters. Wolters Kluwer Health, https://www.wolterskluwer.com/en/expert-insights/why-sponsorship-in-medicine-matters (2020). Ayyala, M.S., et al. Mentorship Is Not Enough: Exploring Sponsorship and Its Role in Career Advancement in Academic Medicine. Acad Med. 94, 94-100 (2019). Lewiss R.E., et al. Is Academic Medicine Making Mid-Career Women Physicians Invisible? J Womens Health (Larchmt). 29,187-192 (2020). Tesch, B.J., Wood, H.M., Helwig, A.L., Nattinger, A.B. Promotion of w

Addressing Disparities and Variations in Care in GU Oncology CME Available: auau.auanet.org/node/37337 Host: Jay D. Raman, MD, FACS Guests: Kelvin Moses, MD, PhD and Svetlana Avulova, MD LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Discuss the impact of race and cultural barriers on optimal GU cancer care. 2. Evaluate financial toxicity as a barrier to optimal patient care in urologic cancer. 3. Incorporate culturally sensitive communications to ensure quality care and reduce biases across diverse patient populations. ACKNOWLEDGEMENTS: This series is supported by independent educational grants from: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc. Sanofi Genzyme

Advancing Women in Urology: Coaching and Self-Advocacy Host: Jay D. Raman, MD, FACS Guest: Dr. Nancy Spector At the conclusion of this activity, participants will be able to: 1. Describe the importance of working with a coach for career advancement and personal growth. 2. List strategies to obtain coaching. 3. Define key attributes of a healthy and effective coaching relationship. ACKNOWLEDGEMENT This educational series was made possible by support from Urovant Resources: Institute of Coaching McLean, Affiliate of Harvard Medical School https://instituteofcoaching.org/coaching-overview/coaching-benefits#:~:text=The%20benefits%20of%20coaching%20are,(source%3A%20ICF%202009 International Coaching Federation https://coachingfederation.org/blog/what-makes-a-great-coach Forbes https://www.forbes.com/sites/forbescoachescouncil/2018/04/24/your-no-fail-guide-to-selecting-an-executive-coach/?sh=85c2cd611e5c

Advancing Women in Urology: Negotiating for Success (2022) Advancing Women in Urology, an exciting new educational initiative, has been designed to elevate awareness and provide content that focuses on career tips, advancement, and education featuring women leaders in all areas of urology. The topic for this live course was based on feedback from an AUA survey and a women-led Steering Committee. Dr. Nancy Spector, Executive Director of Executive Leadership in Academic Medicine (ELAM), will moderate an engaging multi-disciplinary panel of three subject matter experts in an interview-style presentation and discussion. This 1-hour, conversation-style webinar will focus on the topic of Negotiation and includes what to consider when negotiating, negotiation strategies, and the impact of not negotiating. LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Develop a framework for understanding the importance effective negotiation and self-advocacy has on the advancement of wom

Advanced Kidney Cancer: A Guide to Targeted Agents and Immunotherapies CME Available: https://auau.auanet.org/node/37329 Host: Jay D. Raman, MD, FACS Co-Hosts: Monika Joshi, MD, MBBS and Brian Matthew Shuch, MD LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to 1. Discuss the current targeted and immunotherapy options available for the treatment of RCC. 2. Describe both completed and accruing clinical trials that are defining the paradigms of immunotherapy use in RCC. 3. Describe best practices in RCC patient selection for treatment options. 4. Evaluate treatment plans including the sequencing and combination of treatment options for individual patients. ACKNOWLEDGEMENTS: This series is supported by independent educational grants from: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc. Sanofi Genzyme

Advancing Women in Urology: The Importance of Meaningful Mentorship Host: Jay D. Raman, MD, FACS Guests: Anne M. Suskind, MD, MS, FACS, FPMRS and Stacy T. Tanaka, MD, MS Outline: 1. What are the characteristics of a successful mentor or mentee 2. Importance of mentorship for career advancement and personal growth 3. Key characteristics of a healthy/effective relationship 4. Strategies to build effective relationships 5. Why women physicians have difficulty accessing mentors 6. Addressing barriers to acting as a mentor ACKNOWLEDGEMENT This educational series was made possible by support from Urovant

Urothelial Carcinoma: Advances in Immuno-Oncology Host: Jay D. Raman, MD, FACS Co-Hosts: Andrea Apolo, MD and Sima Porten, MD CME Available: auau.auanet.org/node/37325 At the conclusion of this activity, participants will be able to 1. Determine the pros/cons of sequencing strategies with chemotherapy and immunotherapy in first line metastatic urothelial carcinoma. 2. Prioritize treatment options in first line metastatic urothelial carcinoma. 3. Evaluate second line options for metastatic urothelial carcinoma. ACKNOWLEDGEMENTS: This series is supported by independent educational grants from: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc. Sanofi Genzyme

Appropriate use of Biomarker and Genetic Testing in the Diagnosis and Management of Patients with Prostate Cancer Host: Jay D. Raman, MD, FACS Co-Hosts: Veda Giri, MD and Todd Morgan, MD CME Available: auau.auanet.org/node/37313 At the conclusion of this activity, participants will be able to 1. Assess how to maximize the benefits and minimize the harms of prostate cancer detection by carefully selecting patients and by using the necessary tools to detect clinically meaningful prostate cancer while avoiding unnecessary biopsies and detection of clinically unimportant cancers. 2. Discuss the available blood, urine and tissue biomarkers used to enhance detection of higher-grade prostate cancer, the evidence supporting their use and the clinical scenarios in which they are most valuable to be used. 3. Identify the criteria for genetic testing of prostate cancer patients, the gene panels available, and options for testing these men. 4. Utilize the results of genetic testing to improve outcomes among patients

Novel Imaging for Genitourinary Cancers Host: Jay D. Raman, MD, FACS Co-Host: Marc Bjurlin, DO CME Available: https://auau.auanet.org/node/37333 At the conclusion of this activity, participants will be able to 1. Review clinical trials and available PET imaging agents for the detection of prostate, kidney and urothelial cancer. 2. Assess the indications, risks, and benefits of incorporating PET imaging to guide treatment of urologic cancer. ACKNOWLEDGEMENTS: This series is supported by independent educational grants from: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc. Sanofi Genzyme

Systemic Therapies for Metastatic Hormone Sensitive Prostate Cancer and Castrate Resistant Prostate Cancer Host: Jay D. Raman, MD, FACS Co-Host: Alicia Morgans, MD, MPH and Kelly Stratton, MD CME Available: auau.auanet.org/node/37317 At the conclusion of this activity, participants will be able to: 1. Evaluate treatment plans including the sequencing and combination of treatment options for individual patients. 2. Prioritize or stratify treatment options for metastatic prostate cancer. 3. Describe the mechanism of action and role of immune checkpoint inhibitors for advanced prostate cancer. 4. Identify management of side effects and adverse events that patients experience for systemic therapies for advanced prostate cancer. ACKNOWLEDGEMENTS: This series is supported by independent educational grants from: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc. Sanofi Genzyme

Today’s episode is a special preview from the 2022 Update Series. The Update Series, the AUA’s most popular self-study CME product is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. Available in three convenient formats – online, print and audio – the Update Series delivers you 40 concise, practical lessons on timely topics including state-of-the-art surgical techniques. For more episodes like this one or to subscribe to the 2023 Update Series Volume 42, visit the AUAUniversity at auanet.org/update.

Application of the Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline in Clinical Practice Host: Jay D. Raman, MD, FACS Co-Host: Michael S. Cookson, MD, MMHC CME Available: https://auau.auanet.org/node/37309 At the conclusion of this activity, participants will be able to: 1. Interpret the evidence and outcomes on the treatment of M0 HSPC, M1 HSPC, MO CRPC and M1 CRPC as outlined in the newly updated AUA Advanced Prostate Cancer Guideline encompassing metastatic HSPC and CRPC disease. 2. Improve diagnostic and therapeutic decision-making processes by illustrating the application of these guidelines in urological practice. ACKNOWLEDGEMENTS: This series is supported by independent educational grants from: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc. Sanofi Genzyme

Negotiating Skills 101 – Key Steps to Becoming a Good Negotiator Host: Jennifer Miles-Thomas, MD, FPMRS Co-Host: Angelo Baccala, MD, FACS, MBA Welcome to the AUAUniversity Podcast. Today we are announcing the debut of the New AUA Leadership & Business Podcast where urologic professionals can experience the practical application of business acumen essential to successful navigating today’s rapidly changing business environment. We are happy to share with you this AUA Leadership & Business inaugural episode, Negotiating Skills 101 – Key Steps to Becoming a Good Negotiator, where Dr. Angelo Baccala joins host Dr. Jennifer Miles-Thomas to discuss the key points to good negotiating skills that can be used in the workplace as well as personally in day-to-day life. Make AUA Leadership & Business your go-to podcast! Subscribe today by searching “AUA Leadership & Business” on your favorite podcast app.

Primary Palliative Care in Urology Host: Jay D. Raman, MD, FACS Co-Hosts: John L. Gore, MD, MSHS; Jonathan Bergman, MD, MPH Outline: Segment #1: What is palliative care? Segment #2: What evidence is there for the benefit of palliative care? Segment #3: Who supports early palliative care for patients with advanced disease? Segment #4: Why hasn’t access to palliative care been achieved for individuals with advanced disease? Segment #5: What is the current state of palliative care utilization in urology, and is there a better model that could succeed in urology?

AUA Urology Core Curriculum: https://auau.auanet.org/core Host: Jay D. Raman, MD, FACS Co-Host: Priyanka Gupta, MD Outline: 1. Diagnosis and evaluation 2. Non-surgical treatments 3. Urethral bulking agents 4. Open repairs 5. Synthetic slings

Cultural Barriers for Ethnic Minorities CME Available: auau.auanet.org/node/35727 Moderator: Jay D. Raman, MD, FACS Co-Hosts: Adam Murphy, MD, MBA, MSCI LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Identify two specific forms of medical mistrust that can be addressed by clinicians (e.g. belief in doctors as drug pushers incentivized by pharmaceutical companies and belief that placebos are often given to minority patients on clinical trials). 2. Identify common modifiable barriers that impact ethnic minorities (e.g. social support through support groups or patient advocates or home care services or insurance enrollment through critical treatment periods or language). ACKNOWLEDGEMENTS This educational series is supported by independent educational grants from: Astellas AstraZeneca Bayer Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck & Co., Inc. Pfizer, Inc.

AUA Urology Core Curriculum: auau.auanet.org/core Host: Jay D. Raman, MD, FACS Co-Host: Adrien Bernstein, MD Outline: 1. The aging population and their unique needs 2. Geriatric Assessment 3. Practical applications of geriatric centered surgical care 4. Palliative care as part of Geriatric oncology

Host: Jay D. Raman, MD, FACS Guest: A. Lenore Ackerman, MD, PhD For more information or to subscribe to the AUA Update Series, please visit: AUAnet.org/University